Value of inferior vena cava collapsibility index as marker of heart failure in chronic obstructive pulmonary disease exacerbation.


Journal

BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539

Informations de publication

Date de publication:
24 Nov 2023
Historique:
received: 18 05 2023
accepted: 27 10 2023
medline: 27 11 2023
pubmed: 24 11 2023
entrez: 23 11 2023
Statut: epublish

Résumé

Inferior vena cava (IVC) diameter variability with respiration measured by ultrasound was found to be useful for the diagnosis of heart failure (HF) in ED patients with acute dyspnea. Its value in identifying HF in acute exacerbation of chronic obstructive pulmonary disease exacerbation (AECOPD) was not specifically demonstrated. To determine the value of ΔIVC in the diagnosis of HF patients with AECOPD. This is a prospective study conducted in the ED of three Tunisian university hospitals including patients with AECOPD. During this period, 401 patients met the inclusion criteria. The final diagnosis of HF is based on the opinion of two emergency experts after consulting the data from clinical examination, cardiac echocardiography, and BNP level. The ΔIVC was calculated by two experienced emergency physicians who were blinded from the patient's clinical and laboratory data. A cut off of 15% was used to define the presence (< 15%) or absence of HF (≥ 15%). Left ventricular ejection fraction (LVEF) was also measured. The area under the ROC curve, sensitivity, specificity, and positive and negative predictive values were calculated to determine the diagnostic and predictive accuracy of the ΔIVC in predicting HF. The study population included 401 patients with AECOPD, mean age 67.2 years with male (68.9%) predominance. HF was diagnosed in 165 (41.1%) patients (HF group) and in 236 patients (58.9%) HF was excluded (non HF group). The assessment of the performance of the ΔIVC in the diagnosis of HF showed a sensitivity of 37.4% and a specificity of 89.7% using the threshold of 15%. The positive predictive value was 70.9% and the negative predictive value was 66.7%. The area under the ROC curve was 0.71(95%, CI 0.65-0.76). ΔIVC values were not different between HF patients with reduced LVEF and those with preserved LVEF. Our results showed that ΔIVC has a good value for ruling out HF in ED patients consulting for AECOPD.

Identifiants

pubmed: 37996792
doi: 10.1186/s12872-023-03585-1
pii: 10.1186/s12872-023-03585-1
pmc: PMC10668419
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

579

Informations de copyright

© 2023. The Author(s).

Références

JAMA. 1989 Feb 10;261(6):884-8
pubmed: 2913385
Prim Care Respir J. 2010 Dec;19(4):326-34
pubmed: 20842323
Intensive Care Med. 2020 Dec;46(12):2381-2384
pubmed: 32472214
Am J Emerg Med. 2013 Aug;31(8):1208-14
pubmed: 23769272
Ann Emerg Med. 2006 Jul;48(1):66-74
pubmed: 16781921
Chest. 2013 Oct;144(4):1163-1178
pubmed: 23722528
Am J Cardiol. 1987 Jan 1;59(1):125-32
pubmed: 3812222
AJR Am J Roentgenol. 1988 Feb;150(2):431-2
pubmed: 3257336
N Engl J Med. 2004 Mar 4;350(10):1005-12
pubmed: 14999112
World Allergy Organ J. 2011 Jan;4(1 Suppl):S6-8
pubmed: 23283069
Chest. 2000 Oct;118(4):981-9
pubmed: 11035667
Eur J Heart Fail. 2022 Jan;24(1):4-131
pubmed: 35083827
BMJ Open. 2014 Mar 07;4(3):e004546
pubmed: 24607562
Lancet Respir Med. 2020 Jun;8(6):585-596
pubmed: 32526187
Eur Respir J. 2023 Apr 1;61(4):
pubmed: 36858443
J Card Fail. 2010 Jan;16(1):69-75
pubmed: 20123321
J Am Coll Cardiol. 2004 Sep 15;44(6):1328-33
pubmed: 15364340
Eur Respir J. 2008 Nov;32(5):1371-85
pubmed: 18978137
Eur Heart J. 2005 Sep;26(18):1887-94
pubmed: 15860516
Am J Emerg Med. 2009 Jan;27(1):71-75
pubmed: 19041537
Am J Emerg Med. 2015 Mar;33(3):396-401
pubmed: 25612468
Eur J Heart Fail. 2014 Jul;16(7):772-7
pubmed: 24863953
Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55
pubmed: 17507545
J Am Soc Echocardiogr. 2007 Jul;20(7):857-61
pubmed: 17617312
Ann Epidemiol. 2006 Jan;16(1):63-70
pubmed: 16039877
Am J Cardiol. 2005 Apr 15;95(8):948-54
pubmed: 15820160
Indian J Chest Dis Allied Sci. 2010 Oct-Dec;52(4):225-38
pubmed: 21302600
PLoS One. 2016 Mar 24;11(3):e0151981
pubmed: 27010214
Am Rev Respir Dis. 1979 Aug;120(2):421-7
pubmed: 475160
J Am Coll Cardiol. 2007 Jan 16;49(2):171-80
pubmed: 17222727
Monaldi Arch Chest Dis. 1997 Feb;52(1):43-7
pubmed: 9151520
Am J Emerg Med. 2012 Jun;30(5):778-83
pubmed: 21665408
Am J Cardiol. 2009 Jan 15;103(2):246-7
pubmed: 19121445

Auteurs

Cyrine Kouraichi (C)

Research Laboratory LR12SP18, Monastir University, 5000, Monastir, Tunisia.
Emergency Department, Fattouma Bourguiba University Hospital, 5000, Monastir, Tunisia.

Adel Sekma (A)

Research Laboratory LR12SP18, Monastir University, 5000, Monastir, Tunisia.
Emergency Department, Fattouma Bourguiba University Hospital, 5000, Monastir, Tunisia.

Khaoula Bel Haj Ali (K)

Research Laboratory LR12SP18, Monastir University, 5000, Monastir, Tunisia.
Emergency Department, Fattouma Bourguiba University Hospital, 5000, Monastir, Tunisia.

Ikram Chamtouri (I)

Cardiology Department, Fattouma Bourguiba University Hospital, 5000, Monastir, Tunisia.

Sarra Sassi (S)

Research Laboratory LR12SP18, Monastir University, 5000, Monastir, Tunisia.
Emergency Department, Fattouma Bourguiba University Hospital, 5000, Monastir, Tunisia.

Marwa Toumia (M)

Research Laboratory LR12SP18, Monastir University, 5000, Monastir, Tunisia.
Emergency Department, Regional Hospital Ksar Helal, Monastir, Tunisia.

Hajer Yaakoubi (H)

Emergency Department, Sahloul University Hospital, 4011, Sousse, Tunisia.

Rym Youssef (R)

Emergency Department, Sahloul University Hospital, 4011, Sousse, Tunisia.

Mohamed Amine Msolli (MA)

Research Laboratory LR12SP18, Monastir University, 5000, Monastir, Tunisia.
Emergency Department, Fattouma Bourguiba University Hospital, 5000, Monastir, Tunisia.

Kaouthar Beltaief (K)

Research Laboratory LR12SP18, Monastir University, 5000, Monastir, Tunisia.
Emergency Department, Fattouma Bourguiba University Hospital, 5000, Monastir, Tunisia.

Zied Mezgar (Z)

Emergency Department, Farhat Hached University Hospital, 4031, Sousse, Tunisia.

Mariem Khrouf (M)

Emergency Department, Farhat Hached University Hospital, 4031, Sousse, Tunisia.

Wahid Bouida (W)

Research Laboratory LR12SP18, Monastir University, 5000, Monastir, Tunisia.
Emergency Department, Fattouma Bourguiba University Hospital, 5000, Monastir, Tunisia.

Zohra Dridi (Z)

Emergency Department, Farhat Hached University Hospital, 4031, Sousse, Tunisia.

Riadh Boukef (R)

Research Laboratory LR12SP18, Monastir University, 5000, Monastir, Tunisia.
Emergency Department, Sahloul University Hospital, 4011, Sousse, Tunisia.

Hamdi Boubaker (H)

Research Laboratory LR12SP18, Monastir University, 5000, Monastir, Tunisia.
Emergency Department, Fattouma Bourguiba University Hospital, 5000, Monastir, Tunisia.

Mohamed Habib Grissa (MH)

Research Laboratory LR12SP18, Monastir University, 5000, Monastir, Tunisia.
Emergency Department, Fattouma Bourguiba University Hospital, 5000, Monastir, Tunisia.

Semir Nouira (S)

Research Laboratory LR12SP18, Monastir University, 5000, Monastir, Tunisia. semir.nouira.urg@gmail.com.
Emergency Department, Fattouma Bourguiba University Hospital, 5000, Monastir, Tunisia. semir.nouira.urg@gmail.com.
Emergency Department and Laboratory Research (LR12SP18), Fattouma Bourguiba University Hospital, 5000, Monastir, Tunisia. semir.nouira.urg@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH